v3.26.1
Asset Acquisition - Summary of Estimated Fair Value of the Consideration Transferred (Parenthetical) (Details) - Orphai Therapeutics [Member]
May 18, 2026
shares
Business Combination [Line Items]  
No of common stock issued 162,971
Series C Preferred Stock  
Business Combination [Line Items]  
No of common stock issued 67,101.235
Common Stock [Member]  
Business Combination [Line Items]  
No of common stock issued 162,971
Warrant [Member] | Series C Preferred Stock  
Business Combination [Line Items]  
No of common stock issued 10,964.505